Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients
James Neuberger(Queen Elizabeth Hospital Birmingham), Teun van Gelder(Leiden University Medical Center), Bernhard K. Krämer, Franco Citterio, Patrizia Burra(University of Padua), Daniel Serón(Vall d'Hebron Hospital Universitari), Christophe Duvoux(Université Paris-Est Créteil), Stefan Schneeberger(Innsbruck Medical University), Wolf O. Bechstein(Unknown), Pavel Trunečka, Nassim Kamar(Centre National de la Recherche Scientifique), Dirk Kuypers(KU Leuven), Herold J. Metselaar(Erasmus MC), Didier Samuel(Hôpital Paul-Brousse), Jacques Pirenne(Universitair Ziekenhuis Leuven), Alan G. Jardine(Western Infirmary), Frederik Nevens(KU Leuven), Sabina De Geest(University of Basel), Giuseppe Tisone, Manuel Rodríguez‐Perálvarez(Instituto Maimónides de Investigación Biomédica de Córdoba)
Cited by 309
Related Papers
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
|The Lancet|2008|1.9k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Calcineurin Inhibitor Nephrotoxicity
|Clinical Journal of the American Society of Nephrology|2009|1.5k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
|American Journal of Transplantation|2003|1.1k